RTW Biotech Opportunities joins $160.5m Series C of Obsidian Therapeutics
RTW Biotech Opportunities Ltd, an investment company listed on the London Stock Exchange and specialized in the life sciences sector, is proud to announce its participation in the Series C financing round of Obsidian Therapeutics, Inc. The round successfully raised $160.5 million, a testament to the high growth potential seen in Obsidian’s innovative approaches to […]